Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells

Marzia Del Re, Elena Arrigoni, Giuliana Restante, Antonio Passaro, Eleonora Rofi, Stefania Crucitta, Filippo De Marinis, Antonello Di Paolo, Romano Danesi

Research output: Contribution to journalArticle

Abstract

Among the potential mechanisms involved in resistance to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer, the manifestation of stem-like properties in cancer cells seems to have a crucial role. Alterations involved in the development of TKI resistance may be acquired in a very early phase of tumorigenesis, supporting the hypothesis that these aberrations may be present in cancer stem cells (CSCs). In this regard, the characterization of tumor subclones in the initial phase and the identification of the CSCs may be helpful in planning a specific treatment to target selected biomarkers, suppress tumor growth, and prevent drug resistance. The aim of this Review is to elucidate the role of CSCs in the development of resistance to TKIs and its implication for the management of patients.

Original languageEnglish
JournalStem Cells
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Neoplastic Stem Cells
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Tumor Biomarkers
Drug Resistance
Neoplasms
Carcinogenesis
Growth
Therapeutics

Keywords

  • Biomarkers
  • Cancer stem cells
  • Treatment resistance
  • Tumor heterogeneity
  • Tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology

Cite this

Concise Review : Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells. / Del Re, Marzia; Arrigoni, Elena; Restante, Giuliana; Passaro, Antonio; Rofi, Eleonora; Crucitta, Stefania; De Marinis, Filippo; Di Paolo, Antonello; Danesi, Romano.

In: Stem Cells, 01.01.2018.

Research output: Contribution to journalArticle

Del Re, Marzia ; Arrigoni, Elena ; Restante, Giuliana ; Passaro, Antonio ; Rofi, Eleonora ; Crucitta, Stefania ; De Marinis, Filippo ; Di Paolo, Antonello ; Danesi, Romano. / Concise Review : Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells. In: Stem Cells. 2018.
@article{04597f4246614d2c9bb8feee0c1888d8,
title = "Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells",
abstract = "Among the potential mechanisms involved in resistance to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer, the manifestation of stem-like properties in cancer cells seems to have a crucial role. Alterations involved in the development of TKI resistance may be acquired in a very early phase of tumorigenesis, supporting the hypothesis that these aberrations may be present in cancer stem cells (CSCs). In this regard, the characterization of tumor subclones in the initial phase and the identification of the CSCs may be helpful in planning a specific treatment to target selected biomarkers, suppress tumor growth, and prevent drug resistance. The aim of this Review is to elucidate the role of CSCs in the development of resistance to TKIs and its implication for the management of patients.",
keywords = "Biomarkers, Cancer stem cells, Treatment resistance, Tumor heterogeneity, Tyrosine kinase inhibitors",
author = "{Del Re}, Marzia and Elena Arrigoni and Giuliana Restante and Antonio Passaro and Eleonora Rofi and Stefania Crucitta and {De Marinis}, Filippo and {Di Paolo}, Antonello and Romano Danesi",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/stem.2787",
language = "English",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",

}

TY - JOUR

T1 - Concise Review

T2 - Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells

AU - Del Re, Marzia

AU - Arrigoni, Elena

AU - Restante, Giuliana

AU - Passaro, Antonio

AU - Rofi, Eleonora

AU - Crucitta, Stefania

AU - De Marinis, Filippo

AU - Di Paolo, Antonello

AU - Danesi, Romano

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Among the potential mechanisms involved in resistance to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer, the manifestation of stem-like properties in cancer cells seems to have a crucial role. Alterations involved in the development of TKI resistance may be acquired in a very early phase of tumorigenesis, supporting the hypothesis that these aberrations may be present in cancer stem cells (CSCs). In this regard, the characterization of tumor subclones in the initial phase and the identification of the CSCs may be helpful in planning a specific treatment to target selected biomarkers, suppress tumor growth, and prevent drug resistance. The aim of this Review is to elucidate the role of CSCs in the development of resistance to TKIs and its implication for the management of patients.

AB - Among the potential mechanisms involved in resistance to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer, the manifestation of stem-like properties in cancer cells seems to have a crucial role. Alterations involved in the development of TKI resistance may be acquired in a very early phase of tumorigenesis, supporting the hypothesis that these aberrations may be present in cancer stem cells (CSCs). In this regard, the characterization of tumor subclones in the initial phase and the identification of the CSCs may be helpful in planning a specific treatment to target selected biomarkers, suppress tumor growth, and prevent drug resistance. The aim of this Review is to elucidate the role of CSCs in the development of resistance to TKIs and its implication for the management of patients.

KW - Biomarkers

KW - Cancer stem cells

KW - Treatment resistance

KW - Tumor heterogeneity

KW - Tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85041622217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041622217&partnerID=8YFLogxK

U2 - 10.1002/stem.2787

DO - 10.1002/stem.2787

M3 - Article

AN - SCOPUS:85041622217

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

ER -